Evidence map›Paper›PMID 23794138›Full record

ArticleLipids2013

Hydrolysis products generated by lipoprotein lipase and endothelial lipase differentially impact THP-1 macrophage cell signalling pathways.

Yasmin Essaji, Yanbo Yang, Carolyn J Albert, David A Ford, Robert J Brown

Open access · greenAbstract read
In one paragraph

Article in Lipids, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. An immunoregulator nanomedicine approach for the treatment of tuberculosis.Frontiers in bioengineering and biotechnology · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Lipoprotein lipase (LPL) is associated with neurite pathology and its levels are markedly reduced in the dentate gyrus of Alzheimer's disease brains.The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Yasmin Essaji *Department of Biochemistry, Memorial University of Newfoundland, St. John's, NL, A1B 3X9, Canada.
Yanbo Yang *Department of Biochemistry, Memorial University of Newfoundland, St. John's, NL, A1B 3X9, Canada.
Carolyn J AlbertDepartment of Biochemistry and Molecular Biology, School of Medicine, and Center for Cardiovascular Research, Saint Louis University, St. Louis, MO 63104, USA.
David A FordDepartment of Biochemistry and Molecular Biology, School of Medicine, and Center for Cardiovascular Research, Saint Louis University, St. Louis, MO 63104, USA.
Robert J BrownDepartment of Biochemistry, Memorial University of Newfoundland, St. John's, NL, A1B 3X9, Canada.
Memorial University of Newfoundland · CASaint Louis University · US

Funding

Plasmalogen-derived bioactive lipids in atherosclerosisR01HL074214 · NHLBI · SAINT LOUIS UNIVERSITY · PI FORD, DAVID A. · 2004 to 2014
$2.8M
Chlorinated Lipids in Myocardial Ischemia/ReperfusionR21HL111906 · NHLBI · SAINT LOUIS UNIVERSITY · PI FORD, DAVID A. · 2012 to 2013
$404k
NHLBI NIH HHS HL-074214NHLBI NIH HHS HL-111906NHLBI NIH HHS R01 HL074214NHLBI NIH HHS R21 HL111906
6 · The paper itself

Abstract

Macrophages express lipoprotein lipase (LPL) and endothelial lipase (EL) within atherosclerotic plaques; however, little is known about how lipoprotein hydrolysis products generated by these lipases might affect macrophage cell signalling pathways. We hypothesized that hydrolysis products affect macrophage cell signalling pathways associated with atherosclerosis. To test our hypothesis, we incubated differentiated THP-1 macrophages with products from total lipoprotein hydrolysis by recombinant LPL or EL. Using antibody arrays, we found that the phosphorylation of six receptor tyrosine kinases and three signalling nodes--most associated with atherosclerotic processes--was increased by LPL derived hydrolysis products. EL derived hydrolysis products only increased the phosphorylation of tropomyosin-related kinase A, which is also implicated in playing a role in atherosclerosis. Using electrospray ionization-mass spectrometry, we identified the species of triacylglycerols and phosphatidylcholines that were hydrolyzed by LPL and EL, and we identified the fatty acids liberated by gas chromatography-mass spectrometry. To determine if the total liberated fatty acids influenced signalling pathways, we incubated differentiated THP-1 macrophages with a mixture of the fatty acids that matched the concentrations of liberated fatty acids from total lipoproteins by LPL, and we subjected cell lysates to antibody array analyses. The analyses showed that only the phosphorylation of Akt was significantly increased in response to fatty acid treatment. Overall, our study shows that macrophages display potentially pro-atherogenic signalling responses following acute treatments with LPL and EL lipoprotein hydrolysis products.

Indexed as

Anaplastic Lymphoma KinaseCells, CulturedFatty AcidsGas Chromatography-Mass SpectrometryHumansHydrolysisLipaseLipoprotein LipaseLipoproteinsMacrophagesPhosphatidylcholinesPhosphorylationReceptor Protein-Tyrosine KinasesReceptors, Platelet-Derived Growth FactorSignal TransductionVascular Endothelial Growth Factor Receptor-2Anaplastic Lymphoma KinaseFatty AcidsLipaseLIPG protein, humanLipoprotein LipaseLipoproteinsPhosphatidylcholinesReceptor Protein-Tyrosine KinasesReceptors, Platelet-Derived Growth FactorVascular Endothelial Growth Factor Receptor-2

Identifiers

PMID23794138
PMCPMC4727182
OpenAlexW2060513649

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.